SG/CALL/EDWARDS LIFESCIENCES/75/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 03:48:58 2024-06-13 pm EDT | ||
| 1.49 EUR | +0.68% |
|
| Current month | +6.43% | ||
| 1 month | +3.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-13 | 1.49 | +0.68% |
| 24-06-12 | 1.48 | +2.78% |
| 24-06-11 | 1.44 | +5.88% |
| 24-06-10 | 1.36 | -8.72% |
| 24-06-07 | 1.49 | -0.67% |
Delayed Quote Deutsche Boerse AG
Last update June 13, 2024 at 03:48 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU2MAH |
| ISIN | DE000SU2MAH9 |
| Date issued | 2023-11-22 |
| Strike | 75 $ |
| Maturity | 2024-09-20 (99 Days) |
| Parity | 10 : 1 |
| Emission price | 0.88 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.47 € |
|---|---|
| Lowest since issue | 0.78 € |
| Spread | 0.01 € |
| Spread % | 0.68% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.67
USD
Average target price
96.24
USD
Spread / Average Target
+9.77%
- Stock Market
- Warrants
- Warrant
